Less Ads, More Data, More Tools Register for FREE

Pin to quick picksImpax Asset Management Regulatory News (IPX)

Share Price Information for Impax Asset Management (IPX)

Share Price is delayed by 15 minutes
Get Live Data
99.40    -1.20 (-1.19%)
Bid:
98.70
Ask:
99.30
Spread: 0.60 (0.608%)
Market Cap: £120.77m
IPX Live PriceLast checked at - London Stock Exchange

Intraday Impax Asset Management Share Chart

Board Appointment

28 Jun 2022 07:00

RNS Number : 3672Q
Impax Asset Management Group plc
28 June 2022
 

Impax Asset Management Group plc

("Impax" or the "Company")

Board appointment

Impax, the AIM listed specialist investor focused on a more sustainable economy, is pleased to announce the appointment of Annette Wilson as Non-Executive Director, effective 28 June 2022. Annette will sit on the Company's Audit & Risk and Remuneration Committees.

Annette has spent over twenty years in the private equity and venture capital sector. She is a former Partner and COO of Finch Capital and was founding CFO of Palamon Capital Partners, a European growth investor. Prior to joining the private equity sector, Annette worked in the insurance sector at Sedgwick plc, a FTSE 100 company in various roles in the UK, USA and Europe and thereafter was CFO of Windsor PLC, a LSE listed company. She started her career at PricewaterhouseCoopers. Today Annette serves as a Non-Executive Director and Adviser to a number of companies with businesses headquartered in the UK, Singapore and the Netherlands. 

Annette holds a B.Com (Hons) from the University of Johannesburg and is a Fellow of the Institute of Chartered Accountants in England and Wales.

Sally Bridgeland, Chair, said:

"I am pleased to welcome Annette to the Board. She has had an extensive career in the investment sphere including in the private equity and venture capital sectors. Annette's experience in the US and Europe will provide valuable insight as the Company continues to build its global reach."

Annette Wilson said:

"I am delighted to join the Board of Impax. Impax has built a terrific track record of investing successfully in businesses that support the transition to a more sustainable economy. Its growth in AUM across the different regions it operates in is a testament to this. I very much look forward to serving on the Board and its Audit & Risk and Remuneration Committees for the next stage of its development."

During the five years immediately preceding the date of this announcement, Annette Elizabeth Wilson (neé Swardt), who is 62 years old, held the following directorships:

Current

Tech Nation Group Limited

ADHD Embrace (Chair and Trustee)

 

 

Previous

Finch Capital Partners UK Limited

39F Barnes and Richmond Squadron Air Training Corp (Chair and Trustee)

 

 

There is no further information to be disclosed pursuant to Schedule Two Part (g) of the AIM Rules for Companies.

 

LEI number: 213800AJDNW4S2B7E680

- Ends -

 Enquiries:

 Impax Asset Management Group plc

Ian Simm, Chief Executive

Paul French, Head of Corporate Communications

p.french@impaxam.com

 

 

+44 (0)20 3912 3000

+44 (0)20 3912 3032

Montfort Communications

Gay Collins

Jack Roddan

impax@montfort.london

 

 

+44 (0)77 9862 6282

+44 (0)7825 670695

Peel Hunt LLP, Nominated Adviser and Joint Broker

James Britton or Rishi Shah

 

+44 (0)20 7418 8900

 

Berenberg , Joint Broker

Alex Reynolds

 

 

+44 (0)20 3207 7800

 

Notes to Editors - About Impax Asset Management

Founded in 1998, Impax is a specialist asset manager, with approximately £37.0bn / US$46.7bn as of 31 May 2022 in both listed and private markets strategies, investing in the opportunities arising from the transition to a more sustainable global economy.

Impax believes that capital markets will be shaped profoundly by global sustainability challenges, including climate change, pollution and essential investments in human capital, infrastructure and resource efficiency. These trends will drive growth for well-positioned companies and create risks for those unable or unwilling to adapt.

The company seeks to invest in higher quality companies with strong business models that demonstrate sound management of risk. Impax offers a well-rounded suite of investment solutions spanning multiple asset classes seeking superior risk-adjusted returns over the medium to long term.

Impax has ca. 245 staff across six offices in the United Kingdom, the United States, Ireland and Hong Kong, making it one of the investment management sector's largest investment teams dedicated to sustainable development.

 

For more information: www.impaxam.com

Issued in the UK by Impax Asset Management Group plc, whose shares are quoted on the Alternative Investment Market of the London Stock Exchange. Impax Asset Management Group plc is registered in England & Wales, number 03262305. AUM relates to Impax Asset Management Limited, Impax Asset Management (AIFM) Limited, Impax Asset Management Ireland Limited and Impax Asset Management LLC. Impax Asset Management Limited and Impax Asset Management (AIFM) Limited are authorised and regulated by the Financial Conduct Authority and are wholly owned subsidiaries of Impax Asset Management Group plc. Please note that the information provided and links from it should not be relied upon for investment purposes.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAFLFIDRVIDFIF
Date   Source Headline
2nd Jun 20236:01 pmRNSDirector/PDMR Shareholding
31st May 20237:00 amRNSHalf-year Report
26th May 20233:10 pmRNSInvestment Advisory Agreement
26th May 20237:00 amRNSHolding(s) in Company
23rd May 20237:00 amRNSInvestor Presentation of Interim Results
15th May 20232:25 pmRNSHolding(s) in Company
9th May 20237:00 amRNSNotice of Results
11th Apr 20237:00 amRNSQ2 AUM Update
16th Mar 20231:57 pmRNSDirectorate Changes
16th Mar 20231:56 pmRNSResult of AGM
15th Mar 20238:43 amRNSHolding(s) in Company
9th Jan 20237:00 amRNSQ1 AUM update
20th Dec 20223:46 pmRNSDirector/PDMR Shareholding
20th Dec 20223:33 pmRNSHolding(s) in Company
16th Dec 20224:46 pmRNSNotice of AGM
13th Dec 20223:02 pmRNSHolding(s) in Company
1st Dec 20225:06 pmRNSPublication of Annual Financial Report
1st Dec 20227:00 amRNSDirector/PDMR Shareholding
30th Nov 20227:00 amRNSFinal Results
25th Nov 20227:00 amRNSinvestor Presentation of Full Year Results
23rd Nov 20227:00 amRNSNotice of results
21st Nov 20225:05 pmRNSHolding(s) in Company
7th Oct 20227:00 amRNSAUM update
3rd Oct 20228:22 amRNSHolding(s) in Company
13th Sep 202210:49 amRNSHolding(s) in Company
9th Sep 20221:32 pmRNSHolding(s) in Company
2nd Sep 20223:34 pmRNSHolding(s) in Company
12th Aug 20229:37 amRNSDirector/PDMR Shareholding
21st Jul 20225:38 pmRNSHolding(s) in Company
7th Jul 20227:00 amRNSAUM update
6th Jul 20221:50 pmRNSDirector/PDMR and PCA Shareholding
29th Jun 20227:00 amRNSDirector/PDMR Shareholding
28th Jun 20227:00 amRNSBoard Appointment
16th Jun 20224:37 pmRNSDirector/PDMR and PCA Shareholding
14th Jun 20227:00 amRNSHolding(s) in Company
7th Jun 20224:36 pmRNSHolding(s) in Company
1st Jun 20227:00 amRNSInterim results to 31 March 2022
12th May 20228:16 amRNSHolding(s) in Company
12th May 20227:00 amRNSInvestor Presentation of Interim Results
6th May 20227:00 amRNSDate of Interim Results
26th Apr 20223:37 pmRNSHolding(s) in Company
20th Apr 20222:11 pmRNSDirector/PDMR Shareholding
7th Apr 20227:00 amRNSAUM update
30th Mar 20222:14 pmRNSDirector/PDMR Shareholding
29th Mar 20226:10 pmRNSResult of AGM
4th Mar 20222:30 pmRNSDirector/PDMR and PCA Shareholding
25th Feb 20227:00 amRNSAIM Rule 17 Schedule Two (g) Update
14th Feb 20221:24 pmRNSDistribution agreement
10th Jan 20227:00 amRNSAUM update
20th Dec 20216:04 pmRNSNotice of Annual General Meeting ("AGM")

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.